Efficacy of Spironolactone as an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial
Objective: Spironolactone (C24H32O4S), a potent mineralocorticoid receptor (MR) inhibitor, is a potassium-sparing diuretic that is traditionally used to treat fluid build-up in the body or for its anti-androgenic properties. This study is a double-blind, placebo-controlled, randomized clinical tria...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Tehran University of Medical Sciences
2021-12-01
|
| Reeks: | Iranian Journal of Psychiatry |
| Onderwerpen: | |
| Online toegang: | https://ijps.tums.ac.ir/index.php/ijps/article/view/2935 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|